1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Dermal Fillers Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Dermal Fillers Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Dermal Fillers Market Regional Analysis
6.2 North America Dermal Fillers Market Revenue 2021-2031 (US$ Million)
6.3 North America Dermal Fillers Market Forecast Analysis
7. North America Dermal Fillers Market Analysis – by Product
7.1 Biodegradable
- 7.1.1 Overview
- 7.1.2 Biodegradable: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Nonbiodegradable
- 7.2.1 Overview
- 7.2.2 Nonbiodegradable: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Dermal Fillers Market Analysis – by Material
8.1 Calcium Hydroxylapatite
- 8.1.1 Overview
- 8.1.2 Calcium Hydroxylapatite: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Hyaluronic Acid
- 8.2.1 Overview
- 8.2.2 Hyaluronic Acid: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Collagen
- 8.3.1 Overview
- 8.3.2 Collagen: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Poly-L-Lactic Acid
- 8.4.1 Overview
- 8.4.2 Poly-L-Lactic Acid: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Polmethylmethacrylate
- 8.5.1 Overview
- 8.5.2 Polmethylmethacrylate: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Fat Fillers
- 8.6.1 Overview
- 8.6.2 Fat Fillers: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Dermal Fillers Market Analysis – by Application
9.1 Facial Line Correction Treatment
- 9.1.1 Overview
- 9.1.2 Facial Line Correction Treatment: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Lip Enhancement
- 9.2.1 Overview
- 9.2.2 Lip Enhancement: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Face Lift
- 9.3.1 Overview
- 9.3.2 Face Lift: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Scar Treatment
- 9.4.1 Overview
- 9.4.2 Scar Treatment: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. North America Dermal Fillers Market Analysis – by End User
10.1 Multispecialty Hospitals
- 10.1.1 Overview
- 10.1.2 Multispecialty Hospitals: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Dermatology Clinics
- 10.2.1 Overview
- 10.2.2 Dermatology Clinics: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Ambulatory Surgical Centers
- 10.3.1 Overview
- 10.3.2 Ambulatory Surgical Centers: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.4 Others
- 10.4.1 Overview
- 10.4.2 Others: North America Dermal Fillers Market – Revenue and Forecast, 2021-2031 (US$ Million)
11. North America Dermal Fillers Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Dermal Fillers Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 11.2.1.1 North America Dermal Fillers Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Dermal Fillers Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.1.1 US: North America Dermal Fillers Market Breakdown, by Product
- 11.2.1.1.2 US: North America Dermal Fillers Market Breakdown, by Material
- 11.2.1.1.3 US: North America Dermal Fillers Market Breakdown, by Application
- 11.2.1.1.4 US: North America Dermal Fillers Market Breakdown, by End User
- 11.2.1.2 Canada:
North America Dermal Fillers Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.2.1 Canada: North America Dermal Fillers Market Breakdown, by Product
- 11.2.1.2.2 Canada: North America Dermal Fillers Market Breakdown, by Material
- 11.2.1.2.3 Canada: North America Dermal Fillers Market Breakdown, by Application
- 11.2.1.2.4 Canada: North America Dermal Fillers Market Breakdown, by End User
- 11.2.1.3 Mexico :
North America Dermal Fillers Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.3.1 Mexico : North America Dermal Fillers Market Breakdown, by Product
- 11.2.1.3.2 Mexico : North America Dermal Fillers Market Breakdown, by Material
- 11.2.1.3.3 Mexico : North America Dermal Fillers Market Breakdown, by Application
- 11.2.1.3.4 Mexico : North America Dermal Fillers Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 AbbVie Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Galderma SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Merz Pharma GmbH & Co KGaA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Suneva Medical
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 TEOXANE LABORATORIES
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Prollenium Medical Technologies
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Sinclair Pharma Ltd
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations